Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
THYMMUNE THERAPEUTICS INC has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $2,586,728 between 2022 and 2024. These are non-dilutive federal research grants, not equity financing. The company is based in Cambridge, Massachusetts.
No investors recorded yet for THYMMUNE THERAPEUTICS INC.
Add an investorTHYMMUNE THERAPEUTICS INC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for THYMMUNE THERAPEUTICS INC.
Add diversity data